Literature DB >> 4843239

Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.

A R Feinstein.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4843239     DOI： 10.1002/cpt1974161part1110

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  13 in total

Review 1.  Evaluation of safety and tolerance in clinical trials with antimicrobial agents.

Authors:  H Lode; R Stahlmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

2.  Teaching monograph. Tissue reactions to drugs.

Authors:  N S Irey
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

3.  A new approach to identify, classify and count drug-related events.

Authors:  Thomas Bürkle; Fabian Müller; Andrius Patapovas; Anja Sonst; Barbara Pfistermeister; Bettina Plank-Kiegele; Harald Dormann; Renke Maas
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

4.  Diagnosis of acute drug-induced liver injury. Usefulness of clinicopathological patterns and biochemical indices.

Authors:  M Døssing; P B Andreason
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 5.  Detection of drug-induced disease.

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

6.  Assessment of adverse drug reactions in psychiatric hospitals.

Authors:  R Grohmann; H Hippius; B Müller-Oerlinghausen; E Rüther; J Scherer; L G Schmidt; A Strauss; B Wolf
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Detection of drug-induced disease.

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

8.  Methodology and results of a survey of adverse reactons to a drug in private practice.

Authors:  A Spriet; C Spriet; C Larousse; D Chigot; M Roux; P Simon
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

9.  The ambiguity of adverse drug reactions.

Authors:  J Koch-Weser; E M Sellers; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

10.  Toward reducing the ambiguity of adverse drug reactions: a computerized system.

Authors:  M M McCarron
Journal:  J Med Syst       Date:  1982-02       Impact factor: 4.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.